PLAGL2 and hepatocellular carcinoma: To investigate whether epinephrine and USP10 inhibited PLAGL2 protein degradation, we treated HCC cells with the protein synthesis inhibitor cycloheximide (CHX) (Fig. 6e, f, and Supplementary Fig. 7c, d).